Helen Fosam, PhD

A deep dive into the classification criteria, diagnosis, and implications for therapy in axial spondyloarthritis.

A deeper insight into the association between treatment with biologic disease-modifying antirheumatic drugs in rheumatic diseases and risk for type 2 diabetes.

An overview of the increased risk for cardiovascular disease in patients with systemic lupus erythematosus.

An overview of the comparative effectiveness of biologic medications in rheumatoid arthritis.

The risk for cardiovascular disease is grossly underestimated and may account for the disproportionately high percentage of cardiovascular-related deaths in this population.

Researchers have addressed the diagnosis and management of dental and orofacial manifestations in patients with systemic lupus erythematosus, as no guidelines are currently available.

The authors review how to treat acute gout attacks and manage gout long-term, including guidance on when to start urate-lowering therapy, what to use, and how long to treat.

Investigators found data to support the need to tailor individual treatment strategies to improve outcomes in rheumatoid arthritis, which includes further studies to identify biomarkers and patient education about testing and expectations for treatment.

Rheumatologists are expected to play an increasing role in the diagnosis and management of patients with cancer with immune checkpoint inhibitor-related rheumatic diseases.

Researchers found data that showed automated intelligence-based techniques are beneficial in detecting cardiovascular disease caused by the genetic makeup of patients with rheumatoid arthritis.

Understanding genetic factors associated with psoriatic arthritis pathogenesis will support targeted development of new therapies.

Citing recommendations and guidelines from worldwide government agencies and organizations, researchers believe that the consensus supports the safety of vaccinations for patients with rheumatoid arthritis who are undergoing treatment with disease-modifying antirheumatic drugs.

IL-17A inhibitors offer new options in patients with ankylosing spondylitis beyond TNFi agents.

Recent data show that men with rheumatoid arthritis may not fully benefit from self-management programs.

Tools for accurate measurement of serum uric acid level, particularly at low levels, is essential for early gout diagnosis, prompt treatment initiation, and monitoring of treatment effectiveness.

Recent data suggest that the link between circadian rhythms of RA symptoms and the chronotherapy of RA is promising.

Recent evidence links specific bacterial, viral infections, and vaccination to the development of APS, but these associations are not clear-cut.

The risk factors for accelerated cardiovascular disease among young women with SLE remain unclear, with multiple studies producing conflicting results.

Health professionals from many disciplines need to be able to recognize the clinical presentations, essential diagnostic tests, and treatment approach of Lyme neuroborreliosis.

An improved understanding of the gender differences in axial spondyloarthritis can improve disease treatment and reduce disease burden.

Providing guidance to improve dietary behavior, which may include supplementation to achieve an optimal nutritional status, can contribute to improved control of fibromyalgia symptoms.

Addressing the challenges associated with clinical management of calcium pyrophosphate crystal deposition must start with understanding the unmet needs of associated joint damage and establishing a clearly defined strategy to address these needs.

Dietary supplements are widely used by patients with osteoarthritis, but the safety and efficacy of supplements remain unclear and are often misconstrued by mainstream media.

Current guidelines define remission as the absence of clinical and laboratory evidence of significant inflammatory disease, but the tools that are currently available are inadequate to assess clinical remission.

“Infodemiology” and “infoveillance” are terms used to describe an emerging approach to public health research, based on Google Trends big data monitoring and data mining.

Improved survival has ushered in new challenges that inadvertently increase the risk for death in patients with SLE.

Improved treatment in SLE with increased life expectancy has been accompanied by an elevated risk for developing cardiovascular diseases.

Drug-induced lupus erythematosus refers to an idiosyncratic side effect of medications with clinical features similar to the autoimmune-driven idiopathic lupus erythematosus.

The diagnosis and management of shrinking lung syndrome, a rare complication of systemic lupus erythematosus, is discussed in a comprehensive review.

Increasing evidence supports the notion that an individual’s specific response to pain or pain treatments may be affected by particular gene polymorphisms.